Myeloma Cell-Osteoclast Interaction Enhances Angiogenesis Together with Bone Resorption: A Role for Vascular Endothelial Cell Growth Factor and Osteopontin-Reference-Cited by-同舟云学术

Myeloma Cell-Osteoclast Interaction Enhances Angiogenesis Together with Bone Resorption: A Role for Vascular Endothelial Cell Growth Factor and Osteopontin

Published:2007-02-01 Issue:3 Volume:13 Page:816-823
ISSN:1078-0432
Container-title:Clinical Cancer Research
language:en
Short-container-title:Clin Cancer Res

Author:

Tanaka Yoichi,Abe Masahiro,Hiasa Masahiro,Oda Asuka,Amou Hiroe,Nakano Ayako,Takeuchi Kyoko,Kitazoe Kenichi,Kido Shinsuke,Inoue Daisuke,Moriyama Keiji,Hashimoto Toshihiro,Ozaki Shuji,Matsumoto Toshio

Publisher

American Association for Cancer Research (AACR)

Subject

Cancer Research,Oncology

Cited by 143 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advancements in microenvironment-based therapies: transforming the landscape of multiple myeloma treatment;Frontiers in Oncology;2024-07-17

2. The effect of immunomodulatory drugs on bone metabolism of patients with multiple myeloma;Expert Review of Hematology;2024-02-12

3. Circulating sRANKL, Periostin, and Osteopontin as Biomarkers for the Assessment of Activated Osteoclastogenesis in Myeloma Related Bone Disease;Cancers;2023-11-24

4. Inhibition of PI3K Class IA Kinases Using GDC-0941 Overcomes Cytoprotection of Multiple Myeloma Cells in the Osteoclastic Bone Marrow Microenvironment Enhancing the Efficacy of Current Clinical Therapeutics;Cancers;2023-01-11

5. Normalization of the Immunological Microenvironment and Sustained Minimal Residual Disease Negativity: Do We Need Both for Long-Term Control of Multiple Myeloma?;International Journal of Molecular Sciences;2022-12-14